Abstract
Due to the wide range of chemical structures and variety of mechanisms of action of antischizophrenic agents, it is difficult to identify and confirm a common pharmacophore. The present review summarizes various pharmacophore models for antischizophrenic activity including those based on the new targets, the kynurenine aminotransferase (KATs), which may facilitate the development of novel drugs. Some models illustrate the structural differences of compounds with mechanisms of action considered similar, and yet others demonstrate pharmacophore models for similar chemical classes of compounds for which the mechanism of antischizophrenic action is still not clear. In this study, we discuss the pharmacophore models for antipsychotics including phenothiazine, butyrophenone, thioxanthene, and atypical agents along with the novel antischizophrenic agents which are inhibitors of KATs isozymes.
Keywords: Antipsychotic, antischizophrenic, dopamine D2, pharmacophore, KATs inhibitors, serotonin 5-HT2A.
Graphical Abstract
Medicinal Chemistry
Title:Essential Structural Features of Novel Antischizophrenic Drugs: A Review
Volume: 10 Issue: 6
Author(s): Alireza Nematollahi, Noushin Aminimoghadamfarouj and William Bret Church
Affiliation:
Keywords: Antipsychotic, antischizophrenic, dopamine D2, pharmacophore, KATs inhibitors, serotonin 5-HT2A.
Abstract: Due to the wide range of chemical structures and variety of mechanisms of action of antischizophrenic agents, it is difficult to identify and confirm a common pharmacophore. The present review summarizes various pharmacophore models for antischizophrenic activity including those based on the new targets, the kynurenine aminotransferase (KATs), which may facilitate the development of novel drugs. Some models illustrate the structural differences of compounds with mechanisms of action considered similar, and yet others demonstrate pharmacophore models for similar chemical classes of compounds for which the mechanism of antischizophrenic action is still not clear. In this study, we discuss the pharmacophore models for antipsychotics including phenothiazine, butyrophenone, thioxanthene, and atypical agents along with the novel antischizophrenic agents which are inhibitors of KATs isozymes.
Export Options
About this article
Cite this article as:
Nematollahi Alireza, Aminimoghadamfarouj Noushin and Church Bret William, Essential Structural Features of Novel Antischizophrenic Drugs: A Review, Medicinal Chemistry 2014; 10 (6) . https://dx.doi.org/10.2174/1573406410666131229150746
DOI https://dx.doi.org/10.2174/1573406410666131229150746 |
Print ISSN 1573-4064 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6638 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Motor and Sensory Dysfunction in Musician's Dystonia
Current Neuropharmacology Partners in Crime: NGF and BDNF in Visceral Dysfunction
Current Neuropharmacology Molecular Targets in the Rational Design of AD Specific PET Tracers: Tau or Amyloid Aggregates?
Current Alzheimer Research Antidepressant Use During Breastfeeding
Current Women`s Health Reviews Identification of SER-PRO-CYS Peptide in Blood Serum of Multiple Sclerosis Patients
Protein & Peptide Letters Influence of Betaine- and Choline-based Eutectic Solvents on Lipase Activity
Current Biochemical Engineering (Discontinued) Allosteric Inhibitors of Bcr-Abl: Towards Novel Myristate-Pocket Binders
Current Pharmaceutical Biotechnology Vitamin D’s Molecular Action Mechanism in Attention-Deficit/ Hyperactivity Disorder: A Review of Evidence
CNS & Neurological Disorders - Drug Targets miR-7 Replacement Therapy in Parkinson’s Disease
Current Gene Therapy Patent Annotations
Recent Patents on Inflammation & Allergy Drug Discovery Editorial [Hot Topic: Novel Therapeutic Strategies in Neural Diseases Uncover Unexpected Disease Connections: From Neurodegeneration and Addiction to Pain and Depression (Guest Editor: Gonzalo Herradon)]
Current Pharmaceutical Design Metabolomics Analysis for Biomarker Discovery: Advances and Challenges
Current Medicinal Chemistry Neurodevelopmental Delay and Intellectual Disability in Pediatric Heart Transplant
Current Psychiatry Reviews Medicinal Chemistry of Drugs with Active Metabolites Following Conjugation
Mini-Reviews in Medicinal Chemistry Osteopontin; as a Target Molecule for the Treatment of Inflammatory Diseases
Current Drug Targets Perspectives for Drug Intervention in Amyloid Diseases
Current Drug Targets Opioid Peptides and Their Glycoconjugates: Structure-Activity Relationships
Current Medicinal Chemistry - Central Nervous System Agents Protective Effects of Astragalus Membranaceus and Ligustrazine on Rat Brain Microvascular Endothelial Cell Injury after Oxygen-Glucose Deprivation/ Reoxygenation by Suppressing the PKCδ/MARCKS Pathway
Combinatorial Chemistry & High Throughput Screening Past, Present and Future Drugs for the Treatment of Obsessive- Compulsive Disorder
Current Medicinal Chemistry Cannabinoids and Psychosis
Current Pharmaceutical Design